H.I.G. to acquire industrial maintenance services provider Terra Millennium

TAGS

H.I.G. Capital said that one of its affiliates has agreed to acquire , a US-based provider of outsourced industrial maintenance services, from .

The financial terms of the deal were not disclosed.

Established in 1906, the Salt Lake City-based Terra Millennium is engaged in providing mission-critical industrial services. These include mechanical services, refractory design and maintenance, coatings, fireproofing, scaffolding, and insulation.

— Managing Director at H.I.G. Capital said: “We are very excited to partner with Bryan, Mark, and the Terra Millennium team.

See also  Adani Enterprises cashes in $500m—Here’s how it plans to spend it

“There are tremendous opportunities ahead for the Company given its long track record of providing high-quality, reliable service which is enabled by its highly-skilled, national workforce, and best-in-class leadership team.

“The Company has established itself as a leader in the industry, and we look forward to working with Terra Millennium to build upon their success and support continued growth initiatives.”

Terra Millennium is said to cater to a blue-chip customer base across a variety of industrial end markets that include cement, renewables, steel, mining, chemicals, pulp and paper, and refining.

See also  Aon to sell US retirement business and Aon Retiree Health Exchange for $1.4bn

The industrial maintenance services provider has a network of 33 offices across the US.

— Terra Millennium CEO said: “We are well-positioned to continue providing great safety, outstanding quality, and compelling value to each of our customers.

“In partnership with H.I.G., Terra Millennium will be equipped to continue executing on our growth plans and vision for the Company, including deepening our presence in attractive geographies, expanding our service offering and pursuing add-on acquisitions, while maintaining the strong culture that we have developed over the past century.”

See also  Anixa Biosciences files IND with FDA for ovarian cancer CAR-T therapy

The deal, which is subject to customary closing conditions, is likely to close in the second quarter of this year.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This